decad
lectin
recogn
potenti
natur
drug
capabl
treat
rang
diseas
henc
biolog
activ
studi
context
brazilian
biodivers
potenti
provid
wealth
novel
unknown
lectin
mine
novel
bioactiv
lectin
found
broad
rang
organ
land
plant
marin
alga
capabl
discrimin
bind
specif
carbohydr
locat
carbohydr
bind
site
lectin
sugarbind
epitop
ligand
disposit
scaffold
give
rise
varieti
type
interact
lectin
sugar
avid
specif
bind
glycoconjug
reli
carbohydr
recognit
domain
crd
lectin
one
hand
densiti
glycan
glycan
structur
multival
recent
therapeut
potenti
lectin
alga
wide
alga
inde
rich
natur
marin
resourc
lectin
brazilian
coast
may
endow
import
pharmacolog
activ
exampl
lectin
bryothamnion
triquetrum
btl
bryothamnion
seaforthii
bsl
use
differenti
human
colon
carcinoma
cell
algal
cyanobacteri
lectin
cyanovirinn
cvn
show
potent
antivir
activ
also
influenza
viru
ebola
lectin
protein
found
natur
sever
disadvantag
includ
expens
product
scalingup
poor
oral
bioavail
hemagglutin
human
red
blood
cell
mitogen
activ
cellular
toxic
stimul
differentiationactiv
cyanobacteri
lectin
cyanovirin
wellknown
exampl
sever
howev
potenti
compromis
properti
highli
depend
exact
natur
particular
lectin
exampl
mani
lectin
agglutin
red
blood
cell
deriv
sever
anim
speci
mice
rat
rabbit
human
microvirin
alpha
mannosespecif
lectin
microcysti
aeruginosa
shown
compar
antihiv
activ
cyanovirin
much
higher
safeti
profil
prove
less
cytotox
cyanovirin
increas
level
activ
marker
also
highli
potent
antivir
red
algal
lectin
griffithsin
report
outstand
safeti
efficaci
profil
potenti
microbicid
drug
induc
minim
chang
secret
inflammatori
cytokin
chemokin
epitheli
cell
human
pbmc
markedli
upregul
cell
activ
marker
gene
express
measur
effect
cell
viabil
even
case
mitogen
activ
particular
lectin
banana
lectin
banlec
recent
shown
mitogen
activ
could
uncoupl
antivir
activ
engin
lectin
sitedirect
mutagenesi
thu
lectin
modul
remov
nondesir
activ
ie
mitogen
preserv
benefici
activ
ie
antivir
activ
moreov
sinc
carbohydratebind
agent
lectin
prime
candid
drug
prevent
sexuallytransmit
viral
infect
ie
hiv
hbv
hcv
herp
virus
oral
bioavail
drug
requir
even
advantag
poor
absorpt
cell
layer
order
avoid
undesir
system
side
evid
lectin
realist
use
treat
pathogen
infect
vivo
recent
provid
sever
investig
scalabl
manufactur
valid
safeti
antivir
efficaci
griffithsin
mice
rabbit
topic
microbicid
report
okeef
et
takeb
et
kouokam
et
farr
zuend
et
girard
et
interestingli
castilloacosta
et
recent
demonstr
pradimicin
mannosespecif
agent
purifi
actinomyc
madura
cure
mice
suffer
acut
sleep
sick
caus
trypanosom
current
legum
lectin
extens
studi
includ
lectin
seed
plant
belong
fabacea
lablab
lectin
dll
shown
weaken
proangiogen
signal
specif
nuclear
factor
kappa
b
matrix
metalloproteinas
vascular
endotheli
growth
factor
vegf
lectinexpos
culinari
agglutinin
pisum
sativum
agglutinin
capabl
disrupt
hiv
infect
prevent
interact
viral
surfac
glycoprotein
cellular
show
sever
algal
legumin
lectin
brazilian
flora
highli
potent
inhibitor
toward
varieti
virus
discuss
target
site
possibl
mechan
action
purifi
algal
legumin
lectin
initi
investig
inhibitori
activ
two
differ
strain
hiv
rod
assay
infect
perform
human
tlymphocyt
cem
cell
cultur
valu
legum
lectin
conbr
conm
dlasil
dsclerl
found
nanomolar
rang
gener
somewhat
lower
higher
activ
interestingli
dlasil
dsclerl
diocleina
speci
activ
lectin
deriv
canavalia
speci
tabl
second
seri
antihiv
assay
cocultiv
uninfect
persist
cell
express
viral
surfac
glycoprotein
perform
assay
giant
cell
syncytia
deriv
fusion
infect
uninfect
cell
virtu
interact
abundantli
form
within
hour
cocultiv
valu
prevent
giant
cell
format
cocultur
presenc
differ
concentr
lectin
prove
quit
similar
rang
valu
infect
previous
mention
set
tabl
result
indic
legumin
lectin
like
block
adsorptionentri
viru
infect
step
presum
bind
heavili
glycosyl
express
persist
cell
antivir
activ
concentr
legumin
lectin
usual
well
toxic
threshold
tabl
algal
lectin
hml
bsl
aml
mel
much
less
effect
block
activ
legumin
lectin
exampl
wherea
hml
less
effect
activ
dsclerl
lectin
sfl
less
inhibitori
comparison
legumin
dsclerl
lectin
valu
nm
respect
remark
differ
alga
legumin
lectin
illustr
differ
select
recognit
properti
lectin
explor
given
potent
antihiv
activ
sever
lectin
pronounc
effect
syncytium
format
cocultur
bind
lectin
envelop
glycoprotein
cellular
receptor
investig
surfac
plasmon
reson
spr
technolog
preliminari
spr
studi
suggest
hivencod
surfac
glycoprotein
potenti
antivir
target
lectin
attempt
made
determin
bind
constant
kd
relat
associ
ka
dissoci
kd
rate
sinc
interpret
data
complic
known
autoproteolysi
legumin
lectin
fig
glycoprotein
bound
sensor
chip
surfac
bind
lectin
flow
surfac
record
mannosespecif
red
algaederiv
griffithsin
lectin
use
posit
control
assay
select
lectin
promis
valu
includ
dlasil
dsclerl
conbr
conm
sfl
hml
legumin
lectin
dlasil
dsclerl
conbr
conm
appear
show
higher
bind
three
glycoprotein
algal
sfl
hml
lectin
tabl
also
lectin
appear
bind
higher
extent
interestingli
appear
posit
correl
antivir
potenti
lectin
primari
infect
cocultiv
assay
bind
lectin
preliminari
spr
studi
suggest
hivencod
surfac
glycoprotein
potenti
antivir
target
lectin
futur
detail
measur
low
densiti
ligand
sensor
chip
determin
kd
ka
kd
valu
would
worthwhil
problem
autoproteolysi
glycat
control
sinc
besid
hiv
also
influenza
virus
contain
heavili
glycosyl
envelop
three
influenza
virus
influenza
subtyp
influenza
subtyp
influenza
b
investig
use
cytopath
evalu
colour
dyemt
exposur
assay
presenc
lectin
remark
legumin
lectin
dsclerl
show
exquisit
potent
antivir
activ
influenza
infect
low
pm
tabl
prove
activ
conbr
contrast
much
lower
activ
observ
toward
influenza
strain
pm
three
legumin
lectin
also
markedli
activ
influenza
b
viru
higher
picomolarlow
nanomolar
rang
surprisingli
dlasil
highli
activ
hiv
show
poorest
activ
influenza
viru
strain
despit
gener
lower
activ
notic
algal
lectin
ie
aml
also
show
nanomolar
activ
although
highli
depend
natur
influenza
viru
strain
algaederiv
sfl
show
antiinfluenza
viru
activ
subtox
nm
concentr
prove
markedli
cytotox
studi
lectin
notabl
antiinfluenza
viru
activ
legumin
lectin
gener
observ
concentr
markedli
lower
cytotox
concentr
nm
final
activ
nine
lectin
anoth
set
differ
virus
determin
includ
sindbi
viru
coxsacki
viru
punta
toro
viru
felin
corona
viru
fipv
felin
herp
viru
vesicular
stomat
viru
respiratori
syncyti
viru
herp
simplex
viru
ko
herp
simplex
viru
g
herp
simplex
viru
tkko
acv
vaccinia
viru
tabl
assay
lectin
show
promis
activ
toward
virus
sindbi
viru
coxsacki
viru
viru
vaccinia
viru
punta
toro
viru
acquir
immunodefici
syndrom
aid
caus
human
immunodefici
viru
hiv
diseas
compromis
immun
system
predominantli
infect
tcell
dendrit
cell
world
health
organ
predict
next
year
million
peopl
infect
hiv
envelop
viru
possess
lipid
bilay
protect
viral
rna
capsid
surfac
viru
glycosyl
glycoprotein
imbed
part
viral
envelop
start
infect
glycoprotein
bind
receptor
present
tcell
bind
induc
chang
result
exposur
envelop
domain
previous
hidden
moment
bind
host
cell
uncov
domain
may
bind
coreceptor
cell
membran
difficult
antibodi
reach
initiallyuncov
surfac
protein
domain
effici
also
mean
effici
vaccin
avail
yet
hiv
surfac
glycoprotein
one
heavili
glycosyl
protein
known
far
molecular
weight
consist
glycan
therefor
target
glycan
carbohydratebind
agent
cba
propos
earlier
potenti
therapeut
approach
suppress
inde
due
high
specif
bind
carbohydr
chain
cell
surfac
lectin
wide
studi
glycobiolog
field
particip
mani
import
physiolog
sever
lectin
report
antivir
agent
rel
type
virus
investig
beststudi
case
lectin
potent
antivir
ie
hiv
activ
cyanobacteri
cyanovirin
n
algal
lectin
red
algal
lectin
griffithsin
picomolar
potenc
interestingli
sever
lectin
antihiv
activ
show
recognit
differ
carbohydr
exampl
polygonatum
citronella
ophiopogon
japonicu
lectin
affin
sialic
griffithsin
bind
mannoseglucos
structur
cyanovirin
n
predominantli
bind
alpha
mannos
structur
galanthu
nivali
agglutinin
gna
hippeastrum
hybrid
agglutinin
exhibit
mannosebind
musa
acuminata
agglutinin
banlec
bind
high
mannos
carbohydr
latter
lectin
show
differ
degre
antivir
activ
high
picomolar
rang
ie
griffithsin
low
nanomolar
block
viral
entri
major
mechan
antivir
activ
thu
lectin
might
act
antivir
compound
effici
prevent
viral
entri
host
cell
gener
occur
specif
interact
lectin
glycan
expos
glycoprotein
case
hiv
viru
fact
first
lectin
discov
antihiv
activ
cona
bind
glycoprotein
structur
specif
group
found
glycoprotein
block
bind
hiv
receptor
host
conbr
conm
dlasil
dsclerl
report
specif
high
ident
amino
acid
sequenc
cona
lectin
canavalia
dioclea
lectin
differ
amino
acid
sequenc
result
distinct
biolog
activ
notic
data
hiv
show
antivir
potenc
nm
legumin
lectin
algal
lectin
test
gener
less
potent
tabl
alga
lectin
structur
classifi
famili
accord
bind
studi
aml
mel
sfl
belong
oaah
lectin
famili
includ
lectin
marin
red
alga
eucheuma
serra
esa
kappaphycu
alvarezii
kaa
cyanobacteria
oscillatoria
agardhii
oaa
lectin
inhibit
hiv
infect
bind
high
mannos
hm
oligosaccharid
envelop
glycoprotein
carbohydr
profil
indic
famili
antihiv
activ
prefer
link
man
branch
man
pentasaccharid
core
show
high
affin
hm
oaa
recogn
major
high
mannos
sugar
show
similar
valu
support
similar
support
find
algal
lectin
aml
mel
sfl
valu
show
minor
differ
associ
number
sugarbind
epitop
site
glycan
influenc
antihiv
activ
reason
legumin
lectin
superior
antivir
potenti
compar
algaederiv
lectin
studi
may
due
differ
specif
sugar
structur
also
due
tetramer
structur
compar
monomer
conform
algaederiv
lectin
tabl
tetramer
lectin
also
case
hippeastrum
hybrid
amarylli
hha
galanthu
nivali
gna
multipl
carbohydratebind
site
allow
tighter
bind
crosslink
glycan
viral
would
interest
obtain
structur
data
molecular
interact
activ
lectin
complex
hiv
target
gener
nmr
data
xray
base
crystallograph
analysi
andor
cryoem
data
challeng
would
inde
add
significantli
understand
molecular
interact
lectin
glycan
hiv
import
ration
design
mutat
lectin
improv
interact
target
eventu
antivir
efficaci
inde
shown
earlier
lectin
preferenti
specif
usual
show
potent
antivir
hiv
due
presenc
number
cluster
highmannosetyp
glycan
surfac
glycoprotein
also
assum
tetramer
lectin
may
higher
degre
interact
target
glycan
monomer
lectin
result
may
higher
capac
crosslink
glycan
hiv
therebi
freez
glycan
fix
conform
state
decreas
overal
flexibl
surfac
glycoprotein
lectin
show
pronounc
compar
inhibit
primari
hiv
infect
day
assay
giant
cell
format
cocultur
persist
uninfect
tlymphocyt
cell
h
assay
find
highli
suggest
viru
adsorptionentri
underli
mechan
antivir
action
bind
lectin
measur
spr
mark
posit
correl
bind
antivir
activ
strongli
corrobor
hypothesi
fact
lectin
also
measur
bind
might
explain
strong
overal
antihiv
activ
may
make
lectin
somewhat
less
select
griffithsin
strongli
bind
interact
poorli
studi
reveal
whether
addit
bind
lectin
eventu
turnsout
advantag
term
antivir
efficaci
disadvantag
term
potenti
sideeffect
anoth
interest
set
virus
consist
human
influenza
viru
strain
b
particular
influenza
strain
suscept
antigen
drift
andor
shift
subdivid
base
type
envelop
substructur
eg
influenza
viru
type
consist
welldefin
hemagglutinin
ha
neuraminidas
na
subdivid
influenza
viru
bind
sialic
acid
structur
present
host
cell
surfac
viral
accord
literatur
human
vertebr
includ
wild
bird
bat
pig
contract
type
virus
infect
becom
pandem
respons
fifti
million
death
also
caus
highli
destruct
loss
domest
poultri
pose
risk
lectin
red
alga
eucheuma
serra
inhibit
infect
influenza
nm
recogn
high
mannos
nglycan
hm
ha
surfac
cona
also
bind
hm
glycan
show
somewhat
weaker
activ
nm
lectin
aspergillu
oryza
aol
aleuria
aurantia
aal
bind
fucos
less
potent
valu
result
quit
remark
sinc
identifi
legumin
lectin
dsclerl
exquisit
high
activ
influenza
infect
low
nm
tabl
also
conm
exhibit
low
valu
high
activ
nm
influenza
influenza
b
virus
beyond
high
degre
select
lectin
regard
target
influenza
viru
strain
notic
conm
show
higher
activ
toward
influenza
influenza
tabl
strike
differ
antivir
potenti
differ
strain
influenza
viru
may
like
due
often
subtl
differ
glycan
structur
glycan
content
ha
andor
neu
surfac
glycoprotein
virus
studi
wide
investig
promin
studi
interact
lectin
lack
howev
exampl
report
lectin
narcissu
tazetta
ntl
show
respiratori
syncyti
viru
less
potent
find
dlasil
rsv
nm
addit
even
best
activ
influenza
b
viru
nm
influenza
nm
ntl
also
markedli
lower
found
dsclerl
nm
conm
b
nm
current
studi
investig
lectin
isol
brazilian
biodivers
flora
differ
virus
belong
broad
varieti
viral
famili
reveal
remark
panel
highli
activ
lectin
interestingli
activ
lectin
legumin
origin
activ
reach
picomolar
level
pronounc
antivir
potenc
make
attract
novel
agent
investig
antivir
potenti
might
suitabl
topic
applic
find
encourag
investig
potenti
lectin
antivir
agent
lectin
use
studi
well
character
sdspage
fig
mass
spectrometri
ms
primari
structur
determin
describ
literatur
show
similar
level
puriti
report
lectin
conbr
conm
dlasil
dsclerl
purifi
affin
chromatographi
sephadex
column
use
report
lectin
amansia
multifida
aml
bryothamnion
seaforthii
bsl
hypnea
musciformi
hml
meristiella
echinocarpa
mel
solieria
filiformi
sfl
purifi
combin
ammonium
sulphat
precipit
ion
exchang
chromatographi
deaesephacel
column
previous
alga
collect
author
registr
sisbio
sistema
de
e
em
biodiversidad
id
sisgen
sistema
nacion
de
e
conhecimento
tradicion
associado
id
lectin
analyz
sdspage
stain
coomassi
blue
show
consist
high
level
puriti
least
strain
obtain
aid
research
refer
reagent
program
divis
aid
niaid
nih
rod
strain
prof
luc
montagni
time
pasteur
institut
pari
franc
first
seri
antivir
assay
perform
laboratori
rod
strain
human
tlymphocyt
cem
cell
cultur
cell
cultur
infect
dose
viru
dose
infect
number
cell
cultur
determin
titrat
viru
stock
human
tlymphocyt
cem
cell
cultur
dose
ca
use
infect
cem
cell
cultur
cell
per
ml
hiv
flatbottom
microtit
tray
use
receiv
virusinfect
cem
cell
suspens
test
compound
cultiv
time
day
format
virusinduc
giant
cell
determin
quantifi
microscop
second
seri
antivir
experi
consist
cocultiv
assay
wherebi
persist
cell
design
mix
uninfect
tlymphocyt
cell
presenc
differ
concentr
test
compound
syncytium
format
cocultur
determin
quantifi
h
microscop
determin
base
compound
concentr
requir
prevent
syncytium
format
antivir
assay
differ
hiv
base
inhibit
virusinduc
cytopath
human
embryon
lung
hel
use
herp
simplex
viru
type
g
vaccinia
viru
vesicular
stomat
viru
african
green
monkey
vero
use
viru
sindbi
viru
coxsacki
viru
punta
toro
viru
human
cervix
carcinoma
hela
use
vesicular
stomat
viru
coxsacki
viru
respiratori
syncyti
viru
canin
kidney
mdck
use
influenza
influenza
b
viru
crandel
felin
kidney
crfk
use
felin
herp
viru
felin
infecti
periton
viru
cell
cultur
confluent
cell
cultur
microtit
plate
inocul
viru
presenc
vari
concentr
investig
lectin
viral
cytopath
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
lectin
antivir
concentr
express
effect
concentr
lectin
requir
inhibit
virusinduc
cytopath
hel
hela
mdck
cell
obtain
american
type
cultur
collect
atcc
manassa
virginia
usa
crfk
cell
kind
gift
prof
h
egberink
univers
utrecht
utrecht
netherland
specif
interact
lectin
immobil
cellular
receptor
investig
surfac
plasmon
reson
spr
technolog
use
biosensor
biacor
ge
healthcar
uppsala
sweden
lectin
dlasil
dsclerl
conbr
conm
sfl
hml
use
nm
pb
ph
except
dlasil
hml
also
use
nm
inject
min
onto
surfac
sensor
chip
flow
rate
associ
phase
chang
spr
respons
monitor
anoth
min
absenc
compound
dissoci
phase
immobil
immobil
ru
mm
sodium
acet
buffer
ph
author
declar
compet
financi
interest
